Skip to main content
OpenTrials

Clinical trial condition

Sweat Gland Diseases

Explore clinical trials studying Sweat Gland Diseases. Study availability and eligibility vary by location and protocol.

274 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Sweat Gland Diseases trial results

Active, Not Recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • CTT Research Gilbert, Arizona, United States
  • Ctr Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Ctr for Dermatology Clinical Res Fremont, California, United States
View all 131 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

NCT06799000

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Cheryl Effron MD Inc Anaheim, California, United States
View all 138 locations
View Trial Details
Active, Not Recruiting

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

NCT06517732

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Izhevsk, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kazan', Russia
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06212999

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Investigative Site US303 Phoenix, Arizona, United States
  • Investigative Site US240 Scottsdale, Arizona, United States
  • Investigative Site US307 Fort Smith, Arkansas, United States
  • Investigative Site US214 Rogers, Arkansas, United States
View all 165 locations
View Trial Details
Active, Not Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details
Active, Not Recruiting

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

NCT04179175

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Northwest Arkansas Center Rogers, Arkansas, United States
  • MedDerm Associates San Diego, California, United States
  • University Clinical Trials San Diego, California, United States
  • Southern California Skin and Laser Whittier, California, United States
View all 191 locations
View Trial Details
Active, Not Recruiting

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

NCT06361836

Conditions
Autoimmune Diseases, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • SLUCare Academic Pavillion St Louis, Missouri, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, Not Recruiting

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

NCT05139602

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Medical Dermatology Specialists /ID# 240641 Phoenix, Arizona, United States
  • Mayo Clinic - Scottsdale /ID# 241030 Scottsdale, Arizona, United States
  • Burke Pharmaceutical Research /ID# 240811 Hot Springs, Arkansas, United States
  • UCSF Fresno /ID# 240903 Fresno, California, United States
View all 54 locations
View Trial Details

Related conditions